These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. New and emerging biologics in the treatment of inflammatory bowel disease: quo vadis? Danese S; Angelucci E Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S217-27. PubMed ID: 20117345 [TBL] [Abstract][Full Text] [Related]
10. Emerging biological treatments in inflammatory bowel diseases. Van Assche G; Vermeire S; Rutgeerts P Dig Dis; 2006; 24(1-2):131-6. PubMed ID: 16699271 [TBL] [Abstract][Full Text] [Related]
11. How future tumor necrosis factor antagonists and other compounds will meet the remaining challenges in Crohn's disease. Sandborn WJ Rev Gastroenterol Disord; 2004; 4 Suppl 3():S25-33. PubMed ID: 15583528 [TBL] [Abstract][Full Text] [Related]
12. [The role of adhesion molecules for assessing the effectiveness of biological treatment of patients with inflammatory bowel disease]. Boldyreva ON Eksp Klin Gastroenterol; 2012; (5):119-25. PubMed ID: 23402183 [TBL] [Abstract][Full Text] [Related]
13. Anti-TNF therapy in inflammatory bowel diseases: a huge review. Peyrin-Biroulet L Minerva Gastroenterol Dietol; 2010 Jun; 56(2):233-43. PubMed ID: 20485259 [TBL] [Abstract][Full Text] [Related]
15. Introduction and overview: recent advances in the immunotherapy of inflammatory bowel disease. Hibi T; Inoue N; Ogata H; Naganuma M J Gastroenterol; 2003 Mar; 38 Suppl 15():36-42. PubMed ID: 12698869 [TBL] [Abstract][Full Text] [Related]
16. The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in inflammatory bowel disease. Orlando A; Armuzzi A; Papi C; Annese V; Ardizzone S; Biancone L; Bortoli A; Castiglione F; D'Incà R; Gionchetti P; Kohn A; Poggioli G; Rizzello F; Vecchi M; Cottone M; ; Dig Liver Dis; 2011 Jan; 43(1):1-20. PubMed ID: 20843756 [TBL] [Abstract][Full Text] [Related]
17. New therapies for inflammatory bowel disease: from the bench to the bedside. Danese S Gut; 2012 Jun; 61(6):918-32. PubMed ID: 22115827 [TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody therapy of inflammatory bowel disease. van Deventer SJ; Camoglio L Aliment Pharmacol Ther; 1996; 10 Suppl 2():107-11; discussion 112. PubMed ID: 8899109 [TBL] [Abstract][Full Text] [Related]
19. New biologic therapeutics for ulcerative colitis and Crohn's disease. Mozaffari S; Nikfar S; Abdolghaffari AH; Abdollahi M Expert Opin Biol Ther; 2014 May; 14(5):583-600. PubMed ID: 24502344 [TBL] [Abstract][Full Text] [Related]